Last reviewed · How we verify
NCT04490928: CONTRAST
The Problem of Incomplete Myocardial Revascularization in Percutaneous Coronary Intervention in Patients With NSTEMI
trial in NSTEMI in 139 participants. Completed in 28 July 2020.
28 February 2020
Quick facts
| Lead sponsor | National Research Center for Preventive Medicine |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 139 |
| Start date | 1 November 2018 |
| Primary completion | 28 February 2020 |
| Estimated completion | 28 July 2020 |
| Sites | 1 location across Russia |
Conditions studied
- NSTEMI — all drugs for NSTEMI →
Sponsor
National Research Center for Preventive Medicine
Who can join
18 and older, any sex, with NSTEMI. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The study included all patients admitted to the intensive care unit of the district hospital and sent to the angiographic Department for diagnosis and performance of PCI with a diagnosis of NSTEMI, including myocardial infarction (mi) and unstable angina, determined by clinical data, ECG signs and laboratory indicators. Data from patients living in the Sergiev Posad municipal district will be analyzed in order to achieve maximum registration of adverse events during one year of follow-up.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04490928
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for NSTEMI
Currently open trials in the same condition.
- NCT06528821 — AI-Powered ECG Detecting Culprit Vessel Blood Flow Abnormality in ACS · active not recruiting
- NCT05764057 — DAPAgliflozine to Attenuate Cardiac RemOdeling afTEr aCuTe myOcardial Infarction · Phase 3 · recruiting
- NCT05800951 — Can Escalation Reduce Acute Myocardial Infarction Mortality in Cardiogenic Shock · active not recruiting
- NCT04988672 — OPTIMISER Registry - A Prospective Cohort Study to Describe the OPTIMal Management and Outcomes of PatIents PreSEnting W · recruiting
Other National Research Center for Preventive Medicine trials
Trials by the same sponsor.
- NCT04408612 — Dyspnea in Stable Patients With Coronary Artery Disease. · completed
- NCT04522076 — Prospective Hospital Registry of Patients With Suspected or Confirmed Coronavirus Infection (COVID-19) and Community-acq · active not recruiting
- NCT04400500 — Differential Diagnosis and Risk Stratification in Patients With Suspected NSTEACS · completed
- NCT04262583 — Assessment of adherenCe tO Medical theraРy and Its infLuence on Long-term Outcomes In pAtieNts With Heart Failure · completed
- NCT03883282 — Influence of Participation in Randomized Controlled Trials on adheRence to Medicines' Intake and regUlar viSits to the d · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04490928 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by National Research Center for Preventive Medicine
- Last refreshed: 22 September 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04490928.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing